Gareth Mitchell, Author at PsiThera

PsiThera to Participate in Piper Sandler Virtual Novel Targets in Immunology Symposium

Posted on Feb. 12, 2026 (Feb. 12, 2026)

Watertown, Mass., February 12, 2026 (GLOBE NEWSWIRE) — PsiThera, Inc. today announced that Chief Executive Officer Eric Shaff, Founder and Chief Innovation Officer Woody Sherman, Ph.D., and Chief Scientific Officer Camil Sayegh, Ph.D., will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium being held on Friday, February 13,…

PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets

Posted on Dec. 10, 2025 (Dec. 10, 2025)

Watertown, MA, December 10, 2025 — PsiThera, a biotech company harnessing biologically relevant protein states and computational intelligence to create oral drugs for diseases long-constrained by injectable-only approaches, announced today that it has closed a $47.5 million Series A financing and appointed Eric Shaff as Chief Executive Officer. The equity round was led by Samsara Biocapital…